EAT-Lancet diet adherence shrinks waistlines but not weight over five years

Study found no significant relationship between adherence to the EAT-Lancet diet and body weight changes after five years but identified a slight inverse association with waist circumference, indicating a potential benefit in reducing obesity risk and waist size in the long term.

In PhIII data, Eli Lilly’s Retevmo meets primary endpoint of improving progression-free survival

Eli Lilly’s Retevmo to treat advanced or metastatic rearranged during transfection (RET)-mutant medullary thyroid cancer (MTC) showed promising results at improving progression-free survival compared to

August 24, 2023

TikTok takes down accounts for weight loss influencers who discussed Wegovy, Mounjaro

Some weight loss influencers on TikTok have been banned after talking about GLP-1 medications including Novo Nordisk’s Wegovy and Ozempic and Eli Lilly’s Mounjaro. About

July 20, 2023

Health tech funding levels out as startups raise $2.5B in third quarter

Funding for health tech startups might be starting to level out. Digital health startups in the US raised $2.5 billion across 119 deals, according to

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.